CERo Therapeutics Holdings, Inc.

8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 17, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 26, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 29, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 1, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 14, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 11, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Changed accountants; Director or officer change Feb 13, 2026 8-K Other events Feb 4, 2026 8-K Delisting notice or listing-rule failure Feb 3, 2026 8-K Regulation FD disclosure; Other events Jan 7, 2026 8-K Director or officer change; Shareholder vote results Dec 19, 2025 8-K Entered a material agreement Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Delisting notice or listing-rule failure; Other events Oct 30, 2025 8-K Entered a material agreement; Amended charter or bylaws; Other events Oct 16, 2025 8-K Entered a material agreement; Unregistered sale of equity Oct 14, 2025 8-K Regulation FD disclosure Sep 22, 2025 8-K Other events Sep 5, 2025 8-K Delisting notice or listing-rule failure Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 22, 2025 8-K Unregistered sale of equity Jul 18, 2025 8-K Entered a material agreement Jul 14, 2025 8-K Other events Jul 8, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 30, 2025 8-K Other events Jun 17, 2025 8-K Delisting notice or listing-rule failure Jun 13, 2025 8-K Amended charter or bylaws; Other events Jun 11, 2025 8-K Unregistered sale of equity; Other events Jun 6, 2025 8-K Director or officer change Jun 2, 2025 8-K Director or officer change; Shareholder vote results May 29, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Other events May 8, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 28, 2025 8-K Amended charter or bylaws; Regulation FD disclosure Apr 25, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 22, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Other events Feb 12, 2025